C&R Research Inc. Logo

C&R Research Inc.

Leading South Korean CRO offering end-to-end clinical trial services for life science companies.

359090 | KO

Overview

Corporate Details

ISIN(s):
KR7359090008
LEI:
Country:
South Korea
Address:
서울특별시 강남구 역삼로 412 (대치동, 씨엔알빌딩), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

C&R Research Inc. is a leading South Korean contract research organization (CRO) established in 1997. As a pioneer in the nation's clinical trial industry, the company provides comprehensive, end-to-end clinical development services for pharmaceutical, biotechnology, and medical device companies. Its expertise spans the entire trial lifecycle, including early-phase development, trial management, regulatory affairs, data management, and biostatistics. With a track record of over 1,800 domestic and global clinical trials, C&R Research positions itself as a strategic partner for navigating complex clinical pathways. The firm is actively engaged in advancing modern therapeutic areas such as digital therapeutics (DTx) and antibody-drug conjugates (ADCs), serving as a key hub for clients conducting clinical research in Asia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-04-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-04-17 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 90.1 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.3 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 27.7 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 26.4 KB
2025-03-19 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.8 MB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 175.7 KB
2025-03-11 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.2 KB
2025-03-11 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.1 KB
2025-02-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 13.8 KB
2025-02-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.5 KB

Automate Your Workflow. Get a real-time feed of all C&R Research Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for C&R Research Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for C&R Research Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France
ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea
394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy
OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan
2154
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea
153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea
476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan
4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea
002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain
ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea
039200

Talk to a Data Expert

Have a question? We'll get back to you promptly.